Genesee Community College

Recent papers from Genesee Community College

1. Application of genetic features and serial ctDNA in estimating response and prognosis of immunotherapy-based total neoadjuvant therapy (iTNT) for microsatellite stable locally advanced rectal cancer: data from TORCH trialGenome Medicine · 2026
2. Prognostic Significance of Positive Margin-Informed Tumor Status in Esophageal Squamous Cell Carcinoma Using Next-Generation SequencingThe Oncologist · 2026
3. Fragmentia-AI lymphoma: a cfDNA language model for lymphoma detection using ultra-low-pass WGSCell Communication and Signaling · 2026
4. Pamiparib plus surufatinib with ctDNA monitoring in platinum-resistant ovarian cancer after PARP inhibitor progression: a phase Ib/II trial (POST-PARPi)BMC Medicine · 2026
5. Generalizable cancer detection from ultra-low-pass WGS via deep contextual modeling of cfDNA sequencesMolecular Biomedicine · 2026
6. Public Health Leadership, Collaboration, and Negotiation: Learning by DoingPedagogy in Health Promotion · 2026
7. Toward generalizable prediction of cancer signal using a cell-free DNA language modelCell Reports Medicine · 2026
8. Comparative analysis of genomic profiles and clinical outcomes in cholangiocarcinoma and gallbladder cancerScientific Reports · 2026
9. Genomic determinants and an exploratory prognostic model for immunotherapy outcomes in recurrent or metastatic cervical cancerThe Oncologist · 2026
10. Generalizable cancer detection from ultra-low-pass whole-genome sequencing of cell-free DNA using a sequentially fine-tuned transformer framework.Journal of Clinical Oncology · 2026
11. Fragmentia AI–Lymphoma: A cfDNA language model for lymphoma detection using ultra-low-pass WGS.Journal of Clinical Oncology · 2026
12. Multi-omic ctDNA-based MRD for predicting clinical outcomes in advanced NSCLC receiving chemoimmunotherapy.Journal of Clinical Oncology · 2026
13. Development and validation of a multidimensional cfDNA assay for cancer detection and tissue-of-origin prediction.Journal of Clinical Oncology · 2026
14. Longitudinal plasma and CSF ctDNA profiling as used to define therapeutic landmarks and compartmentalized clonal evolution in rhabdomyosarcoma.Journal of Clinical Oncology · 2026
15. Longitudinal circulating tumor DNA surveillance as predictor of progression in advanced non-small-cell lung cancer with long-term benefit to immunotherapy.Journal of Clinical Oncology · 2026
16. Tumor-naïve multimodal cfDNA MRD assay to predict recurrence in a prospective cohort of patients undergoing curative-intent lung cancer resection.Journal of Clinical Oncology · 2026
17. Multi-modal liquid biopsy integrating cfDNA fragmentomics and serum biomarkers for the differential diagnosis of ovarian tumors.Journal of Clinical Oncology · 2026
18. Predicting neoadjuvant chemoradiotherapy response and postoperative recurrence in locally advanced rectal cancer using a preoperative large language model.Journal of Clinical Oncology · 2026
19. MARM: a framework for malignancy risk prediction from host-derived CNV in bronchoalveolar lavage fluid mNGS data with microbial admixtureFrontiers in Microbiology · 2026
20. Burden and temporal trends of non-communicable diseases from 1990 to 2021 and prediction to 2035 in the group of twenty countries: a systematic analysis of the Global Burden of Disease Study 2021Frontiers in Microbiology · 2026